glp 1 clinical studies The transformative breakthroughs in GLP-1 research recognized by the 2024 Lasker~DeBakey award | Current Medicine GLP-1-based therapies for diabetes, obesity

Results from the OUTSTAND-1 trial showed Hengrui/Kailera's HRS-7535 (KAI-7535) cut HbA1c by a highest placebo-adjusted 1.62% at 32 weeks, based on the treatment efficacy estimand.

Discover how protein helps preserve muscle and keep you full.

With an FY18 Multiple Sclerosis Research Program Investigator-Initiated Research Award, Dr

SUPPORTS GLP 1 LEVELS AND GUT HEALTH: Eriomin is a unique citrus bioflavonoid extract that may help support digestive wellness by contributing to a balanced intestinal environment and support gut health as part of a healthy lifestyle

This article explores current clinical evidence, provider decision-making frameworks, and how genetic insights may inform a personalized conversation with your healthcare

These revolutionary injections are designed to help individuals